Similar articles for PMID: 14644858

Year	Number of Results
2000	1
2001	5
2002	8
2003	6
2004	8
2005	8
2006	8
2007	19
2008	11
2009	14
2010	11
2011	11
2012	11
2013	5
2014	5
2015	1
2016	2
2017	1
2018	1
2021	2
2022	2
2024	0

1

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense.

van Vollenhoven R, Harju A, Brannemark S, Klareskog L. van Vollenhoven R, et al. Ann Rheum Dis. 2003 Dec;62(12):1195-8. doi: 10.1136/ard.2003.009589. Ann Rheum Dis. 2003. PMID: 14644858 Free PMC article.

2

Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital.

Wick MC, Ernestam S, Lindblad S, Bratt J, Klareskog L, van Vollenhoven RF. Wick MC, et al. Scand J Rheumatol. 2005 Sep-Oct;34(5):353-8. doi: 10.1080/03009740510026887. Scand J Rheumatol. 2005. PMID: 16234182

3

[Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab].

Sanmartí R, Gómez-Puerta JA, Rodríguez-Cros JR, Albaladejo C, Muñoz-Gómez J, Cañete JD. Sanmartí R, et al. Med Clin (Barc). 2004 Mar 13;122(9):321-4. doi: 10.1016/s0025-7753(04)74223-2. Med Clin (Barc). 2004. PMID: 15033049 Clinical Trial. Spanish.

4

Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.

Jonsdottir T, Forslid J, van Vollenhoven A, Harju A, Brannemark S, Klareskog L, van Vollenhoven RF. Jonsdottir T, et al. Ann Rheum Dis. 2004 Sep;63(9):1075-8. doi: 10.1136/ard.2003.018093. Epub 2004 Apr 5. Ann Rheum Dis. 2004. PMID: 15066863 Free PMC article.

5

Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects.

Iannone F, Trotta F, Montecucco C, Giacomelli R, Galeazzi M, Matucci-Cerinic M, Ferri C, Cutolo M, Maria Bambara L, Triolo G, Ferraccioli G, Valentini G, Lapadula G; GISEA (Gruppo Italiano per lo Studio delle Early Arthritis). Iannone F, et al. Ann Rheum Dis. 2007 Feb;66(2):249-52. doi: 10.1136/ard.2006.058776. Epub 2006 Jul 12. Ann Rheum Dis. 2007. PMID: 16837489 Free PMC article.

6

Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.

Schabert VF, Watson C, Joseph GJ, Iversen P, Burudpakdee C, Harrison DJ. Schabert VF, et al. J Manag Care Pharm. 2013 Oct;19(8):621-30. doi: 10.18553/jmcp.2013.19.8.621. J Manag Care Pharm. 2013. PMID: 24074008 Free PMC article.

7

Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.

Markenson JA, Gibofsky A, Palmer WR, Keystone EC, Schiff MH, Feng J, Baumgartner SW. Markenson JA, et al. J Rheumatol. 2011 Jul;38(7):1273-81. doi: 10.3899/jrheum.101142. Epub 2011 May 15. J Rheumatol. 2011. PMID: 21572150

8

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

Geborek P, Crnkic M, Petersson IF, Saxne T; South Swedish Arthritis Treatment Group. Geborek P, et al. Ann Rheum Dis. 2002 Sep;61(9):793-8. doi: 10.1136/ard.61.9.793. Ann Rheum Dis. 2002. PMID: 12176803 Free PMC article.

9

The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.

Cohen G, Courvoisier N, Cohen JD, Zaltni S, Sany J, Combe B. Cohen G, et al. Clin Exp Rheumatol. 2005 Nov-Dec;23(6):795-800. Clin Exp Rheumatol. 2005. PMID: 16396697

10

Outcomes of switching anti-TNF drugs in rheumatoid arthritis--a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN).

Virkki LM, Valleala H, Takakubo Y, Vuotila J, Relas H, Komulainen R, Koivuniemi R, Yli-Kerttula U, Mali M, Sihvonen S, Krogerus ML, Jukka E, Nyrhinen S, Konttinen YT, Nordström DC. Virkki LM, et al. Clin Rheumatol. 2011 Nov;30(11):1447-54. doi: 10.1007/s10067-011-1779-1. Epub 2011 Jun 7. Clin Rheumatol. 2011. PMID: 21644062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

116 results

Results by year